Impacts of FDA and Healthcare Regulatory and Enforcement Policy Changes

To help clients effectively address the challenges involved in achieving compliance with the ever-increasing variety of regulatory requirements, we invite you to join us for a new webinar series. Each one-hour program will offer practical guidance from our experts pertaining to one of today’s most pressing regulatory issues.

The first presentation in the series provides a high-level overview of select FDA and healthcare regulatory and enforcement policy changes that impact the industry, including regulatory and risk management considerations for clinical trials and relaxation of certain FDA and healthcare regulations that help to facilitate companies in their development and commercialization of their products. The following topics will be covered during this webinar:

• Clinical trials during the COVID-19 public health emergency
• Coronavirus Treatment Acceleration Program (CTAP)
• Select FDA guidance and enforcement policies relevant for manufacturers and digital health companies
• Key healthcare regulatory updates during the COVID-19 public health emergency, e.g., HIPAA waiver, Stark law, CARES Act

We hope you will join us.

Thursday, June 18
9:00 a.m. – 10:00 a.m. Pacific

COMING UP

Thursday, June 25
9:00 a.m. – 10:00 a.m. Pacific
CFIUS Status:  Final Stages of FIRRMA Implementation, Early in the Enforcement Era

Thursday, July 9
9:00 a.m. – 10:00 a.m. Pacific
Huawei, Foreign-Produced Goods and Other Hot US Export Control Topics

*Registration for these sessions to follow. Additional webinar dates and topics will be announced shortly.